GLUE
MODERATEMonte Rosa Therapeutics, Inc.
CIK: 0001826457
Sell
(70% confidence)
Last activity: Jan 7, 2026
Financial Metrics
As of Dec 31, 2024 (10-K)
Net Income -$72.70M
Total Cash $224.25M
Current Ratio 2.40
Insider Roster (6 total, 6 active)
| Insider | Buys | Sells | Net Value | Holdings |
|---|---|---|---|---|
| Warmuth Markus President & CEO | 0 | 4 | -$282K | 620,696 shares $14.43M |
| Nickson Philip Chief Business & Legal Officer | 0 | 1 | -$48K | 60,845 shares $923K |
| Janku Filip Chief Medical Officer | 0 | 1 | -$48K | 75,026 shares $1.14M |
| Townson Sharon Chief Scientific Officer | 0 | 1 | -$48K | 67,845 shares $1.03M |
| Champoux Jennifer Chief Operating Officer | 0 | 1 | -$40K | 62,371 shares $946K |
| Dunn Edmund Principal Accounting Officer | 0 | 1 | -$16K | 22,693 shares $344K |
Recent Transactions
SELL Warmuth Markus (President & CEO)
3,707 shares @ $23.24
$86K
Jan 7, 2026
Conviction: |
View SEC Filing →
SELL Warmuth Markus (President & CEO)
1,450 shares @ $23.88
$35K
Jan 7, 2026
Conviction: |
View SEC Filing →
SELL Warmuth Markus (President & CEO)
309 shares @ $24.57
$8K
Jan 7, 2026
Conviction: |
View SEC Filing →
SELL Warmuth Markus (President & CEO)
10,135 shares @ $15.17
$154K
Jan 5, 2026
Conviction: |
View SEC Filing →
SELL Nickson Philip (Chief Business & Legal Officer)
3,155 shares @ $15.17
$48K
Jan 5, 2026
Conviction: |
View SEC Filing →
SELL Janku Filip (Chief Medical Officer)
3,155 shares @ $15.17
$48K
Jan 5, 2026
Conviction: |
View SEC Filing →
SELL Townson Sharon (Chief Scientific Officer)
3,155 shares @ $15.17
$48K
Jan 5, 2026
Conviction: |
View SEC Filing →
SELL Champoux Jennifer (Chief Operating Officer)
2,629 shares @ $15.17
$40K
Jan 5, 2026
Conviction: |
View SEC Filing →
SELL Dunn Edmund (Principal Accounting Officer)
1,039 shares @ $15.17
$16K
Jan 5, 2026
Conviction: |
View SEC Filing →
⚠️ Important Disclaimer
• This is AI-generated analysis for educational purposes only, not financial advice.
• Insider trading data is derived from SEC Form 4 filings and may contain errors.
• Always conduct your own research and consult qualified financial advisors before making investment decisions.